Avalon Pharma (Middle East Pharmaceutical)

Update in progress

4016.SR (Saudi)

Company RatingNeutral
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic

Middle East Pharmaceutical Industries Company develops, manufactures, and markets generic medicines and pharmaceutical preparations in Saudi Arabia and abroad. It serves private, public, and export segments, with products across dermatology, respiratory, cardiovascular, GI, anti-infectives, musculoskeletal, genitourinary, and CNS fields. The firm exports its products and was formerly Middle East Chemical Products Factory, renamed in 2006. It was founded in 1998 and is based in Riyadh.

Company score

Sentiment: 0.32; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.00; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.00; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.00; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.16; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive